Global Ear-Nose-Throat (ENT) Devices Market to Surpass USD 26 Billion By 2025

April 20, 2020


As per the report titled ‘Ear-Nose-Throat (ENT) Devices Market Size By Product Type Industry Analysis Report, Regional Outlook , Application Potential, Competitive Market Share & Forecast, 2019 - 2025’ available with Market Study Report LLC, global ear-nose-throat (ENT) devices market is projected to cross USD 26 million by the year 2025.
 

Increasing prevalence of ear, nose, and throat diseases among the adult population is the primary growth determinant of ear-nose-throat (ENT) devices market. According to Hearing Loss Association of America (HLAA) and CDC, hearing impairment is the third most prevalent disease with around 25% Americans suffering from tinnitus. CDC also reported that 12.1% of adult Americans are detected with sinusitis. These factors coupled with increased pervasiveness of pharyngitis and throat cancer is bolstering the demand for ENT devices.
 

Technological advancements in ENT devices such as Medtronic’s otological burs and drills that offer high accuracy with user-friendly design are enhancing the market growth. Advanced endoscopes and navigation systems are introduced which are capable of aiding otolaryngologists throughout complex surgical treatment procedures. Rising implementation of digital signal processing with new applications in hearing aids and implants is expected boost the adoption of these products. On the contrary, high cost associated with ENT devices and costly surgical procedures will hinder the market growth in the coming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/467738/
 

As per the product landscape, flexible endoscopes segment was worth USD 1.1 billion in 2018. Wide ranging applications of flexible endoscopy in micro-invasive surgical procedures is driving the segment growth. The device offers benefits such as enhanced patient safety and minimal patient exposure to chemical germicide and other microbial infections.
 

The report cites that nasal splints segment is expected to exhibit 5.1% CAGR over the forecast timeline. Nasal splints allow post-operative breathing by maintaining the integrity of the nasal structure. They are extensively used in surgical procedures for stabilizing healing septum and enable septal compression. Enhanced safety of nose from trauma and retention of bone position are other factors encouraging the use of nasal splints.
 

Considering the regional terrain, Europe ear-nose-throat devices market is projected to grow with a CAGR of 7.3% through 2025. The growth can be credited to increasing elderly population base suffering from ENT diseases, especially rhinosinusitis. Government initiatives towards reduction of surgical costs, in tandem with stringent quality check of ENT devices by various regulatory authorities including EU commission has augmented the growth of ENT market in Europe. Furthermore, increase in number of startups in industry due to ever growing demand for ENT devices and favorable trade policies are expected to expand the regional business landscape in the ensuing years.
 

Prominent players in ear-nose-throat devices market are Cochlear Limited, Atos Medical, GN Hearing A/S, Rion Co. Ltd., Sonova, Siemen's Healthcare, Starkey Hearing Technologies, Widex A/S, William Demant Holding A/S, and Welch Allyn.


Frequently Asked Questions (FAQ) :

Increasing prevalence of ear, nose, and throat diseases among the adult population is the primary growth determinant of ear-nose-throat devices market.
High cost associated with ENT devices and costly surgical procedures will hinder the market growth in the coming years.
Increasing elderly population base suffering from ENT diseases, especially rhinosinusitis along with favorable government policies and stringent quality check of ENT devices by various regulatory authorities including EU commission is augmenting the growth of ENT devices market in Europe.
Prominent players of ear-nose-throat market are Cochlear Limited, Atos Medical, GN Hearing A/S, Rion Co. Ltd., Sonova, Siemen's Healthcare, Starkey Hearing Technologies, Widex A/S, William Demant Holding A/S, and Welch Allyn.